instruqcia: informacia pacientisTvis finalgoni 4 mg/25 mg TiToeul ...
instruqcia: informacia pacientisTvis finalgoni 4 mg/25 mg TiToeul ...
instruqcia: informacia pacientisTvis finalgoni 4 mg/25 mg TiToeul ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
orsuloba da laqtacia<br />
nebismieri medikamentis miRebamde rekomendaciisTvis eqims an farmacevts mimarTeT.<br />
orsulobis da ZuZuTi kvebis ganmavlobaSi gamoyenebisas <strong>finalgoni</strong>s efeqtebis Sesaxeb<br />
monacemebis ararsebobis gamo, am periodebSi preparatis gamoyeneba ar aris rekomendebuli.<br />
avtomanqanis da meqanizmebis marTva<br />
avtomanqanis da meqanizmebis marTvis unarze <strong>finalgoni</strong>s efeqtebis Sesaxeb kvlevaTa monacemebi<br />
ar aris xelmisawvdomi.<br />
mniSvnelovani <strong>informacia</strong> <strong>finalgoni</strong>s zogierTi komponentis Sesaxeb<br />
malamo <strong>finalgoni</strong> damxmare nivTierebis saxiT Seicavs sorbinis mJavas, romelsac SeuZlia kanis<br />
adgilobrivi reaqciebis gamowveva (magaliTad, kontaqturi dermatitis).<br />
3. <strong>finalgoni</strong>s gamoyenebis wesi<br />
<strong>finalgoni</strong> yovelTvis zustad eqimis daniSnulebisamebr gamoiyeneT. Tu rameSi darwmunebuli ar<br />
xarT, gaesaubreT eqims an farmacevts.<br />
xelisgulis zomis zedapirze waisviT ara umetes ½ sm (daaxloebiT muxudos marcvlisodena)<br />
malamo <strong>finalgoni</strong>.<br />
mkurnaloba yovelTvis <strong>finalgoni</strong>s Zalian dabali doziT unda daiwyos, romelsac kanis patara<br />
ubanze waisvamT, individualuri reaqciis Sesamowmeblad. finalgonze sapasuxo reaqcia Zlier<br />
gansxvavebulia da zogierT pirs, hiperemiuli efeqtis misaRebad, malamos mxolod mcire<br />
raodenoba esaWiroeba.<br />
malamo <strong>finalgoni</strong> nela waisviT mxolod dazianebul zedapirze, SefuTvaSi Semavali<br />
mowyobilobis gamoyenebiT. <strong>finalgoni</strong>s gamoyenebis Semdeg, xelebi sapniTa da wylis uxvi<br />
raodenobiT unda daibanoT.<br />
malamo <strong>finalgoni</strong> saWiroebis mixedviT, dReSi ara umetes 2-3-jer gamoiyeneT.<br />
bavSvebi<br />
monacemebis ararsebobis gamo, <strong>finalgoni</strong>s gamoyeneba 12 wlamde asakis bavSvebSi ar aris<br />
rekomendebuli.<br />
tubis boloSi arsebuli aluminis sacobi basri sagnis meSveobiT srulad unda gaixvritos.<br />
Tu <strong>finalgoni</strong> saWiroze didi raodenobiT gamoiyeneT<br />
Tu <strong>finalgoni</strong> saWiroze didi raodenobiT miiReT, rCevisTvis Tqvens eqims an farmacevts<br />
mimarTeT.<br />
Tu SemTxveviT, <strong>finalgoni</strong> didi raodenobiT waisviT, efeqtis Semcireba kanis zeTiani naWriT<br />
(magaliTad, sakvebi zeTi) an cximiani kremiT gawmendiT SeiZleba.<br />
<strong>finalgoni</strong>s Warbad gamoyenebis Semdeg, sisxlis mimoqceva SeiZleba gaizardos da misi gverdiTi<br />
efeqtebi damZimdes. Warbi raodenobiT wasmam SesaZlebelia zemoqmedebis ubnis kanze buStukebis<br />
warmoqmna gamoiwvios.<br />
<strong>finalgoni</strong>s dozis gadaWarbebam, agreTve, SeiZleba sxeulis zeda nawilSi gamonayari, sxeulis<br />
temperaturis momateba, wamoxurvebebi, sisxlis cirkulaciis mtkivneul SegrZnebamde gaZliereba<br />
da sisxlis dabali wneva gamoiwvios.<br />
Tu <strong>finalgoni</strong>s gamoyeneba dagaviwydaT<br />
Tu <strong>finalgoni</strong>s gamoyeneba dagaviwydaT, gaxsenebisTanave waisviT, magram gamotovebulis<br />
anazRaurebis mizniT ormagi doza ar gamoiyenoT.<br />
Tu <strong>finalgoni</strong>s gamoyeneba SewyviteT<br />
<strong>finalgoni</strong> mxolod saWiroebis SemTxvevaSi gamoiyeneba da simptomebis gaumjebesebis Semdeg misi<br />
wasma unda Sewydes.<br />
preparatis Sesaxeb damatebiTi kiTxvebis SemTxvevaSi, mimarTeT Tqvens eqims an farmacevts.<br />
4. SesaZlo gverdiTi efeqtebi<br />
yvela sxva preparatis msgavsad, finalgonmac SeiZleba gverdiTi efeqtebi gamoiwvios, Tumca ara<br />
yvela pacientSi.<br />
gverdiTi efeqtebi dajgufebulia sixSiris mixedviT da Semdegia:<br />
Zalian xSiri (uviTardeba 10-dan 1 pacientze mets);<br />
xSiri (uviTardeba 10-dan 1 pacientze naklebs);<br />
naklebad xSiri (uviTardeba 100-dan 1 pacientze naklebs);<br />
iSviaTi (uviTardeba 1000-dan 1 pacientze naklebs);<br />
Zalian iSviaTi (uviTardeba 10000-dan 1 pacientze naklebs).<br />
<strong>finalgoni</strong>s savaWro licenzirebis Semdgom gamocdilebaze dayrdnobiT, SesaZlebelia Semdegi<br />
gverdiTi efeqtebis ganviTareba:<br />
imunuri sistemis darRvevebi:<br />
ucnobis sixSiris: Tu alergiuli (hipersensitiuri) xarT, anafilaqsiuri reaqciebi.<br />
nervuli sistemis darRvevebi:<br />
naklebad xSiri: Cxvletis SegrZnebebi (paresTezia);<br />
ucnobi sixSiris: kanqveSa wvis SegrZneba.<br />
sunTqvis darRvevebi gulmkerdis areSi – mediastinaluri:<br />
ucnobi sixSiris: xvela, sunTqvis gaZneleba.